These findings may also contribute to the colonic cancer risk in IBD which relates to inflammatory burden, given the ability of CCR9/CCL25 interactions to mediate colonic tumour growth, invasion and metastasis [40]. Here, CCR9 is linked to malignant colon neoplasm.